Autologous bone marrow cell therapy for patients with peripheral arterial disease: a meta-analysis of randomized controlled trials

Bibliography

• Hirsch AT, Criqui MH, Treat-Jacobson D, Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;11:1317-24
   Google Scholar
• Lawall H, Bramlage P, Amann B. Treatment of peripheral arterial disease using stem and progenitor cell therapy. J Vasc Surg 2011;53:445-53
   PubMed Web of Science ®Google Scholar
• Franz RW, Parks A, Shah KJ, Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease. J Vasc Surg 2009;50:1378-90
   PubMed Web of Science ®Google Scholar
• Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost 2010;103:696-709
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Nishigami K, Nagaya N, Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 2006;114:2679-84
   PubMed Web of Science ®Google Scholar
• Kim DI, Kim MJ, Joh JH, Angiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger's disease. Stem Cells 2006;24:1194-200
   PubMed Web of Science ®Google Scholar
• Napoli C, Farzati B, Sica V, Beneficial effects of autologous bone marrow cell infusion and antioxidants/l-arginine in patients with chronic critical limb ischemia. Eur J Cardiovasc Prev Rehabil 2008;15:709-18
   PubMed Web of Science ®Google Scholar
• Tateishi-Yuyama E, Matsubara H, Murohara T, Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427-35
   PubMed Web of Science ®Google Scholar
• Huang P, Li S, Han M, Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005;28:2155-60
   PubMed Web of Science ®Google Scholar
• Arai M, Misao Y, Nagai H, Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease. Circ J 2006;70:1093-8
   Google Scholar
• Dash NR, Dash SN, Routray P, Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res 2009;12:359-66
   PubMed Web of Science ®Google Scholar
• Prochazka V, Gumulec J, Jaluvka F, Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant 2010;19:1413-24
   PubMed Web of Science ®Google Scholar
• Walter DH, Krankenberg H, Balzer JO, Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (provasa). Circ Cardiovasc Interv 2011;4:26-37
   PubMed Web of Science ®Google Scholar
• Lu D, Chen B, Liang Z, Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract 2011;92:26-36
   PubMed Web of Science ®Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13
   PubMedGoogle Scholar
• Liu T, Li G, Li L, Korantzopoulos P. Association between c-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2007;49:1642-8
   PubMed Web of Science ®Google Scholar
• Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-6
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60
   PubMed Web of Science ®Google Scholar
• Martin-Rendon E, Brunskill SJ, Hyde CJ, Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008;29:1807-18
   PubMed Web of Science ®Google Scholar
• Feringa HH, Karagiannis SE, Schouten O, Prognostic significance of declining ankle-brachial index values in patients with suspected or known peripheral arterial disease. Eur J Vasc Endovasc Surg 2007;34:206-13
   PubMed Web of Science ®Google Scholar
• Sprynger M, Fassotte C, Verhaeghe R. The ankle-brachial pressure index and a standardized questionnaire are easy and useful tools to detect peripheral arterial disease in non-claudicating patients at high risk. Int Angiol 2007;26:239-44
   PubMed Web of Science ®Google Scholar
• Sprengers RW, Moll FL, Verhaar MC. Stem cell therapy in pad. Eur J Vasc Endovasc Surg 2010;39(Suppl 1):S38-43
   Google Scholar
• Pignon B, Sevestre MA, Chatelain D, Histological changes after implantation of autologous bone marrow mononuclear cells for chronic critical limb ischemia. Bone Marrow Transplant 2007;39:647-8
   PubMed Web of Science ®Google Scholar
• Duong Van Huyen JP, Smadja DM, Bruneval P, Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia. Mod Pathol 2008;21:837-46
   PubMed Web of Science ®Google Scholar
• Gulati R, Simari RD. Defining the potential for cell therapy for vascular disease using animal models. Dis Model Mech 2009;2:130-7
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kalka C, Masuda H, Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-8
   PubMed Web of Science ®Google Scholar
• Kawamura A, Horie T, Tsuda I, Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. J Artif Organs 2006;9:226-33
   PubMedGoogle Scholar
• Sivan-Loukianova E, Awad OA, Stepanovic V, CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res 2003;40:368-77
   PubMed Web of Science ®Google Scholar
• Al-Khaldi A, Al-Sabti H, Galipeau J, Lachapelle K. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 2003;75:204-9
   PubMed Web of Science ®Google Scholar
• Iwase T, Nagaya N, Fujii T, Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 2005;66:543-51
   PubMed Web of Science ®Google Scholar
• Lasala GP, Silva JA, Gardner PA, Minguell JJ. Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis. Angiology 2010;61:551-6
   PubMed Web of Science ®Google Scholar
• Dudley AC, Udagawa T, Melero-Martin JM, Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors. Blood 2010;116:3367-71
   PubMed Web of Science ®Google Scholar
• Melero-Martin JM, De Obaldia ME, Kang SY, Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 2008;103:194-202
   PubMed Web of Science ®Google Scholar
• Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis 2010;209:10-17
   PubMed Web of Science ®Google Scholar
• Haspel RL, Miller KB. Hematopoietic stem cells: source matters. Curr Stem Cell Res Ther 2008;3:229-36
   PubMedGoogle Scholar
• Zhang M, Methot D, Poppa V, Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001;33:907-21
   PubMed Web of Science ®Google Scholar
• Reffelmann T, Kloner RA. Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease. Regen Med 2009;4:709-19
   PubMed Web of Science ®Google Scholar
• Horie T, Onodera R, Akamastu M, Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells. Atherosclerosis 2010;208:461-6
   PubMed Web of Science ®Google Scholar